adagrasib,Pembrolizumab
mirati,merck
['nsclc', 'sclc', 'ca,022,i', 'ca,022,1', 'lung']
new #lungcancer cancer research: dana-farber's pasi j nne, md, phd, presents research at #esmoimmuno22 looking at a combination precision therapy in advanced non-small cell lung cancer and says the results are meaningful and encouraging. abstract here 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090